OptraSCAN, the California-headquartered digital pathology company backed by Molbio Diagnostics, has received USFDA 510(k) clearance for its integrated digital pathology system, marking a major milestone in AI-driven cancer diagnostics and digital pathology innovation.
Tag: diagnostics
Molbio Diagnostics Wins KOCHON Prize 2024 for TB Innovation
Molbio Diagnostics has been awarded the KOCHON Prize 2024 by the Stop TB Partnership, recognizing its pioneering work in ensuring access to cutting-edge diagnostic tools and innovation in the fight against tuberculosis (TB). This distinction makes Molbio the first private company globally—and the third Indian entity after ICMR and Dr. L.S. Chauhan—to receive the prestigious award.
Molbio Diagnostics Files DRHP with SEBI: Plans ₹200 Crore Fresh Issue, Major Expansion Ahead
Goa-based Molbio Diagnostics, backed by Temasek and MOPE, has filed its DRHP with SEBI for an IPO comprising a fresh issue of ₹200 crore and an OFS of 1.25 crore equity shares. The funds will be utilized for R&D infrastructure, manufacturing expansion, and corporate purposes.
Goa Makes Healthcare History with India’s First Pricing Policy for Innovative Lifesaving Therapies
Goa Health Minister Shri. Vishwajit Rane unveiled the nation’s first Pricing Policy for Innovative Lifesaving Therapies (PPILT), aimed at ensuring fair, transparent, and sustainable pricing for critical medicines, diagnostics, and advanced medical devices